Industrial Partners

Home / Industrial Partners

Since Bruno Torres acquired MEDITEST in 2007, the company has had 20 suppliers providing original materials.

MEDITEST has exclusive distribution agreements. For some, international distribution outside France is possible.

The company’s main suppliers are RADCAL, CIRS, DATA SPECTRUM, and ASHLAND.


Since 2007, suppliers have been selected and renewed by quality indicators, and this has resulted in a reduced number. Some world-renowned manufacturers such as RADCAL or CIRS have chosen MEDITEST as their exclusive technical ambassador for their companies within France.

Examples of dynamic industrial partnerships that have been established with manufacturers RADCAL and CIRS:


RADCAL is an industry leader in the design and manufacturing of ionizing radiation measuring systems for equipment using X-rays.

Radcal has an active Research and Development program which is committed to offering new and improved user-oriented X-ray measurement tools used by manufacturers, physicists, biomedical engineers, and government inspectors.

RADCAL’s beginnings can be traced to 1975 when RADCAL (then MDH) designed the 1015 for the United States Food and Drug Administration (US FDA) to measure medical X-ray dose rate, dose, and time without range changing or loss of accuracy when interchanging detectors. The 1015, commonly referred to as “The MDH,” introduced new technology to the industry, and with our Gold Standard ion chambers, users experienced unmatched performance, accuracy, ease of use, and reliability. Today, more than 35 years later, many 1015s are still in active use around the world.

Beyond its tight working relationship with RADCAL, and despite the distance, MEDITEST works closely with its teams in various aspects:


To provide a solution dedicated to all market players,


To refine MEDIX LAB’s calibration work so it has the widest possible range of equipment adaptation,


To create a local solution to make the MEDIX LAB offer available at a European level for the entire distribution network,


To optimize the profitability of MEDIX LAB’s operating procedures.


To diversify internationally (within reason) to perfect its area of expertise.

Within the scope of this industrial partnership with RADCAL, other developments are underway and make up MEDITEST’s showcase of new, potential offers at a national and international level.


The leader in tissue simulation, CIRS, is recognized worldwide for tissue simulation technology and the manufacturing of phantoms and simulators for quantitative densitometry, calibration, quality control, and research in the field of medical imaging and radiotherapy.

Computerized Imaging Reference Systems (CIRS)

Founded in 1983, CIRS started out by seeking to improve the existing tissue simulation methodology and provide quantitative reference standards for computed tomography (CT).

Today, CIRS is recognized as a leader in the manufacturing of tissue-equivalent phantoms and simulators for medical imaging, radiotherapy, and procedural training.

CIRS is one of few companies worldwide with proprietary technology that permits the manufacture of phantoms for every commercial imaging modality. Applications include Original Equipment Manufacturer (OEM) production quality control, service, R&D, and pre-clinic trials. The company also provides custom design and manufacturing services to support research into new modalities and techniques.

CIRS employs a diverse group of people with specific knowledge in physics, computational modeling, chemistry, computer aided design, bio-modeling, tool and mold design, pattern making, resin casting, plastics fabrication, machining, electronics engineering, and software development.

Through global partnerships, CIRS, headquartered in Norfolk, VA (USA), distributes its products and services worldwide. Promotional efforts include tradeshows, website and internet marketing, an extensive worldwide network of independent manufacturing representatives, etc.

Within the scope of the industrial partnership, MEDITEST works closely with CIRS teams to develop new offers, such as specific phantoms.